Home Cart Sign in  
Chemical Structure| 129580-63-8 Chemical Structure| 129580-63-8

Structure of Satraplatin
CAS No.: 129580-63-8

Chemical Structure| 129580-63-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Satraplatin is a platinum-based antineoplastic agent that is under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy.

Synonyms: BMS182751; BMY45594; JM216

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Satraplatin

CAS No. :129580-63-8
Formula : C10H22Cl2N2O4Pt
M.W : 500.28
SMILES Code : [Cl-][Pt+4]([O-]C(C)=O)([O-]C(C)=O)([Cl-])([NH3])[NH2]C1CCCCC1
Synonyms :
BMS182751; BMY45594; JM216

Safety of Satraplatin

Related Pathways of Satraplatin

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00265655 Metastatic Breast Cancer Phase 2 Completed - United States, Texas ... More >> US Oncology Dallas, Texas, United States, 75204 Less <<
NCT00329329 Malignancies Phase 1 Terminated(Sponsor decided to ... More >>discontinue study drug development) Less << - United States, Illinois ... More >> Northwestern University Medical Center Chicago, Illinois, United States, 60611 Less <<
NCT00069745 Prostate Cancer ... More >> Hormone Refractory Prostate Cancer Less << Phase 3 Completed - -
NCT00125411 Tumors Phase 1 Terminated(Sponsor decided to ... More >>discontinue study drug development.) Less << - United States, Wisconsin ... More >> University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00499694 Prostate Cancer Not Applicable Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States, 48201 Less <<
NCT00313456 Tumors Prosta... More >>te Cancer Less << Phase 1 Terminated(Sponsor decided to ... More >>discontinue study drug development) Less << - United States, Tennessee ... More >> Sarah Cannon Research Institute Nashville, Tennessee, United States Less <<
NCT01259479 Solid Tumors ... More >>Brain Tumors Brain Metastases Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00480623 Prostate Cancer Phase 1 Terminated(Sponsor decided to ... More >>discontinue study drug development) Less << - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, Texas UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78230 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00634647 Prostate Cancer ... More >> Genetic Polymorphism Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Associates in Oncology and Hematology Rockville, Maryland, United States, 20850 Less <<
NCT00450970 Prostate Cancer Phase 3 Terminated(Sponsor decided to ... More >>discontinue study drug development.) Less << - -
NCT00499694 - Completed - -
NCT00268970 Non-small Cell Lung Cancer Phase 2 Completed - United States, Tennessee ... More >> Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT03258320 Prostate Cancer Patients Phase 1 Recruiting December 2020 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Qingdao, Shandong, China, 266035 Contact: Jiannan Chen, Ph.D    86-0532-96599654    submarinesuny@yahoo.com    China Zhongshan Hospital Recruiting Shanghai, China, 200032 Contact: Qilai Long, Ph.D    86-15821758764    long.qilai@zs-hospital.sh.cn Less <<
NCT00093132 Carcinoma, Non-small Cell Lung... More >> Lung Cancer Less << Phase 1 Phase 2 Terminated(Sponsor decided to ... More >>discontinue study drug development.) Less << - United States, Texas ... More >> Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00473720 Advanced Cancers Phase 1 Completed - United States, Connecticut ... More >> Yale University, Comprehensive Cancer Center New Haven, Connecticut, United States, 06520 Less <<
NCT01289067 - Completed - -
NCT01289067 Prostate Cancer Phase 2 Completed - United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 Less <<
NCT01220284 Advanced Solid Tumors Phase 1 Unknown February 2011 Switzerland ... More >> Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland, 6500 Kantonspital Graubünden Chur, Switzerland, 7000 Less <<
NCT00370383 Lung Cancer Phase 2 Completed - United States, California ... More >> Pacific Cancer Medical Center Anaheim, California, United States, 92801 Scripps Clinic La Jolla, California, United States, 92037 Kenmar Research Institute Los Angeles, California, United States, 90057 United States, Florida Memorial Cancer Institute Hollywood, Florida, United States, 33021 University of Miami Sylvester Cancer Center Miami, Florida, United States, 33136 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Ohio Highlands Oncology Group Bentonville, Ohio, United States, 72712 Gabrail Cancer Center Canton, Ohio, United States, 44718 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Signal Point Hematology/Oncology Middleton, Ohio, United States, 45042 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19110 Canada McGill University Montreal, Canada Princess Margaret Hospital Toronto, Canada Chile Hospital San Borja Arriaran Santiago, Chile Instituto Nacional del Cancer Santiago, Chile Research Center Santiago, Chile Less <<
NCT00634647 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.00mL

0.40mL

0.20mL

9.99mL

2.00mL

1.00mL

19.99mL

4.00mL

2.00mL

References

 

Historical Records

Categories